UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032468
Receipt number R000037020
Scientific Title Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor
Date of disclosure of the study information 2018/05/03
Last modified on 2018/11/01 11:57:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Acronym

Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Scientific Title

Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Scientific Title:Acronym

Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Region

Japan


Condition

Condition

Peripheral lung lesion

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the additional effect on safety and patient's satisfaction with analgesics combined with sedative bronchoscopy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The patient satisfaction score 2 hours after bronchoscopy using a visual analogue scale (VAS)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Administration of midazolam during bronchoscopy

Interventions/Control_2

Administration of midazolam and fentanyl during bronchoscopy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1) Over 20 years old and under 90 years
2) Adaptation of bronchoscopy (EBUS-GS)
3) Written consent has been obtained

Key exclusion criteria

1) History of severe drug allergy
2) Contraindications to use of midazolam and fentanyl
3) Using any opioids
4) Severe hypoxemia or hypercapnia
5) History of severe heart, lung, liver, kidney, neuromuscular disease
6) History of epilepsy
7) History of symptomatic cerebral infarction
8) During pregnancy or possible pregnancy
9) Emergency procedure
10) Bronchoscopy other than EBUS-GS
11) Other conditions inappropriate for participating in the study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naohiko Hamaguchi

Organization

Ehime University School of Medicine

Division name

Department of Cardiology, Pulmonology, Hypertension and Nephrology

Zip code


Address

Shitsukawa, Toon, Ehime

TEL

089-960-5303

Email

guri0531@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takahide Kato

Organization

Ehime University School of Medicine

Division name

Department of Cardiology, Pulmonology, Hypertension and Nephrology

Zip code


Address

Shitsukawa, Toon, Ehime

TEL

089-960-5303

Homepage URL


Email

kato.takahide.tn@ehime-u.ac.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛媛大学医学部附属病院(愛媛県)


Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 04 Month 23 Day

Date of IRB


Anticipated trial start date

2018 Year 05 Month 03 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 05 Month 03 Day

Last modified on

2018 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037020


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name